Table. Global Projected COPD Prevalence, Cases, and Relative Change From 2020 to 2050 by Sex.
| Sex | 2020 | 2030 | 2040 | 2050 |
|---|---|---|---|---|
| Female | ||||
| Prevalence, % | 7.8 | 8.1 | 8.34 | 8.33 |
| Cases, No. | 176 776 887 | 210 351 803 | 240 030 181 | 260 106 028 |
| Relative change in prevalence, % | NA | 3.8 (vs 2020) | 2.5 (vs 2030) | −0.12 (vs 2040); 6.4 (vs 2020) |
| Relative change in cases, % | NA | 19.0 (vs 2020) | 14.1 (vs 2030) | 8.4 (vs 2040); 47.1 (vs 2020) |
| Male | ||||
| Prevalence, % | 13.4 | 12.5 | 11.6 | 10.6 |
| Cases | 303 080 615 | 322 532 353 | 333 145 741 | 331 449 760 |
| Relative change in prevalence, % | -NA | −6.7 (vs 2020) | −7.2 (vs 2030) | −8.6 (vs 2040); −20.9 (vs 2020) |
| Relative change in cases, % | NA | 6.4 (vs 2020) | 3.3 (vs 2030) | −0.5 (vs 2040); 9.4 (vs 2020) |
| Global | ||||
| Prevalence, % | 10.6 | 10.3 | 9.7 | 9.5 |
| Cases, No. | 479 857 502 | 532 884 156 | 573 175 922 | 591 555 788 |
| Relative change in prevalence, % | NA | −2.8 (vs 2020) | −5.8 (vs 2030) | −2.1 (vs 2040); −10.4 (vs 2020) |
| Relative change in cases, % | NA | 11.0 (vs 2020) | 7.6 (vs 2030) | 3.2 (vs 2040); 23.3 (vs 2020) |
Abbreviation: NA, not applicable.